MedKoo Cat#: 585247 | Name: TJN 505

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TJN 505 is an aconitine-like compound found to suppress various canine ventricular and atrial arrhythmias and seems to act as a blocker of multiple channels.

Chemical Structure

TJN 505
CAS#141426-86-0

Theoretical Analysis

MedKoo Cat#: 585247

Name: TJN 505

CAS#: 141426-86-0

Chemical Formula: C30H42ClNO7

Exact Mass: 563.2650

Molecular Weight: 564.12

Elemental Analysis: C, 63.88; H, 7.50; Cl, 6.28; N, 2.48; O, 19.85

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
TJN 505; TJN505; TJN-505
IUPAC/Chemical Name
(11-ethyl-5,8-dihydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl) 4-methoxybenzoate;hydrochloride
InChi Key
OTWHFNPJXVKZPR-UHFFFAOYSA-N
InChi Code
InChI=1S/C30H41NO7.ClH/c1-5-31-15-17-8-11-22(36-3)30-19(17)12-20(25(30)31)28(33)14-23(37-4)29(34)13-21(30)24(28)26(29)38-27(32)16-6-9-18(35-2)10-7-16;/h6-7,9-10,17,19-26,33-34H,5,8,11-15H2,1-4H3;1H
SMILES Code
[H]Cl.O=C(OC1C2C3C4(C5C6)C(OC)CCC5CN(CC)C4C6C2(O)CC(OC)C1(O)C3)C7=CC=C(OC)C=C7
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 564.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gonzalez-Estrada A, Reddy K, Dimov V, Eidelman F. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opin Pharmacother. 2017 Aug;18(11):1137-1143. doi: 10.1080/14656566.2017.1346085. Epub 2017 Jul 9. Review. PubMed PMID: 28656804. 2: Bhat V, Kennedy SH. Recognition and management of antidepressant discontinuation syndrome. J Psychiatry Neurosci. 2017 Jun;42(4):E7-E8. PubMed PMID: 28639936; PubMed Central PMCID: PMC5487275. 3: Lassen D, Ennis ZN, Damkier P. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review. Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):32-6. doi: 10.1111/bcpt.12497. Epub 2015 Nov 3. Review. PubMed PMID: 26435496. 4: Jaeschke RR, Sowa-Kućma M, Pańczyszyn-Trzewik P, Misztak P, Styczeń K, Datka W. Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile. Pharmacol Rep. 2016 Aug;68(4):748-55. doi: 10.1016/j.pharep.2016.04.002. Epub 2016 Apr 22. Review. PubMed PMID: 27203278. 5: Arita J, Xue YX, Aye NN, Fukuyama K, Wakui Y, Niitsu K, Maruno M, Siying C, Hashimoto K. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models. Eur J Pharmacol. 1996 Dec 30;318(2-3):333-40. PubMed PMID: 9016923. 6: Smyj R, Wang XP, Han F. Tramadol hydrochloride. Profiles Drug Subst Excip Relat Methodol. 2013;38:463-94. doi: 10.1016/B978-0-12-407691-4.00011-3. Review. PubMed PMID: 23668411. 7: Giovannoni G, Hawkes C, Waubant E, Lublin F. The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies. Mult Scler Relat Disord. 2017 Jul;15:A1-A2. doi: 10.1016/j.msard.2017.06.005. PubMed PMID: 28641776. 8: Tibrewal P, Cheng R, Bastiampillai T, Dhillon R, Okungu A, Campbell J. Lurasidone-Induced Dystonia. Prim Care Companion CNS Disord. 2017 Jun 29;19(3). pii: 16l02053. doi: 10.4088/PCC.16l02053. PubMed PMID: 28682525. 9: Theurer P. [Not Available]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2016 Sep;51(9):514. doi: 10.1055/s-0042-113427. Epub 2016 Sep 15. German. PubMed PMID: 27631441. 10: Chen J, Zhong B, Wang Y. Agranulocytosis Induced by Sinomenine Hydrochloride. Am J Case Rep. 2017 Sep 6;18:959-962. PubMed PMID: 28874654; PubMed Central PMCID: PMC5597034. 11: Souri E, Ahmadi FS, Barazandeh Tehrani M, Hosseini MM, Fadaye Vatan S. Validated Spectrophtometric Method for Simultaneous Determination of Buprenorphine and Naloxone in Pharmaceutical Dosage Forms. Iran J Pharm Res. 2017 Winter;16(1):112-119. PubMed PMID: 28496466; PubMed Central PMCID: PMC5423238. 12: Bellantuono C, Vargas M, Mandarelli G, Nardi B, Martini MG. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review. Hum Psychopharmacol. 2015 May;30(3):143-51. doi: 10.1002/hup.2473. Epub 2015 Mar 18. Review. PubMed PMID: 25784291. 13: Ibrahim MM, Elzanfaly ES, El-Zeiny MB, Ramadan NK, Kelani KM. Spectrophotometric determination of meclizine hydrochloride and pyridoxine hydrochloride in laboratory prepared mixtures and in their pharmaceutical preparation. Spectrochim Acta A Mol Biomol Spectrosc. 2017 May 5;178:234-238. doi: 10.1016/j.saa.2017.02.013. Epub 2017 Feb 8. PubMed PMID: 28199928. 14: Gao T, Shi T, Wiesenfeld-Hallin Z, Li T, Jiang JD, Xu XJ. Sinomenine facilitates the efficacy of gabapentin or ligustrazine hydrochloride in animal models of neuropathic pain. Eur J Pharmacol. 2019 Jul 5;854:101-108. doi: 10.1016/j.ejphar.2019.03.061. Epub 2019 Apr 4. PubMed PMID: 30954565. 15: Salter TG, Williams MD. Antidepressant-Associated Microscopic Colitis: A Case Report and Literature Review. Psychosomatics. 2017 May - Jun;58(3):307-312. doi: 10.1016/j.psym.2017.01.005. Epub 2017 Jan 19. Review. PubMed PMID: 28347506. 16: Akuta N, Kumada H, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y, Suzuki F, Arase Y, Ikeda K. Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial. Hepatol Res. 2018 Sep;48(10):810-813. doi: 10.1111/hepr.13075. Epub 2018 Apr 24. PubMed PMID: 29601141. 17: Hashi Y, Kondo T. [Fingolimod]. Nihon Rinsho. 2015 Sep;73 Suppl 7:205-11. Japanese. PubMed PMID: 26480701. 18: Bayes M, Rabasseda X, Prous JR. Gateways to Clinical Trials. June 2002. Methods Find Exp Clin Pharmacol. 2002 Jun;24(5):291-327. Review. PubMed PMID: 12168506. 19: Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010 Jan-Feb;32(1):47-86. PubMed PMID: 20383346. 20: Marsden J. Breast cancer chemoprevention: A service in need of menopause specialist support. Post Reprod Health. 2017 Mar;23(1):15-21. doi: 10.1177/2053369116685452. Epub 2017 Jan 12. Review. PubMed PMID: 28081658.